Trial Identifier: | D9483R00001 |
Sponsor: | AstraZeneca |
NCTID:: | NCT05271266 |
Start Date: | March 2022 |
Primary Completion Date: | December 2023 |
Study Completion Date: | December 2023 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
China | Dalian, China |
China | Dalian, China |
China | Dalian, China |
China | Dalian, China |
China | Dalian, China |
China | Dalian, China |
China | Dalian, China |
China | Dalian, China |
China | Dalian, China |
China | Dalian, China |
China | Dalian, China |
China | Dalian, China |
China | Dalian, China |
China | Dalian, China |
China | Dalian, China |
China | Dalian, China |
China | Dalian, China |
China | Dalian, China |
China | Dalian, China |
China | Dalian, China |
China | Dalian, China |
China | Dalian, China |
China | Dalian, China |
China | Dalian, China |
China | Dalian, China |
China | Dalian, China |
China | Dalian, China |
China | Dalian, China |
China | Dalian, China |
China | Dalian, China |
China | Shanghai, China |